Laboratory Ebit from 2010 to 2026

LH Stock  USD 282.63  4.52  1.63%   
Laboratory's EBIT is increasing with slightly volatile movements from year to year. EBIT is predicted to flatten to about 863.6 M. For the period between 2010 and 2026, Laboratory, EBIT quarterly trend regression had mean deviation of  382,695,449 and range of 2.8 B. View All Fundamentals
 
EBIT  
First Reported
1989-03-31
Previous Quarter
361.8 M
Current Value
393 M
Quarterly Volatility
207.6 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Laboratory financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Laboratory's main balance sheet or income statement drivers, such as Interest Expense of 251.5 M, Total Revenue of 15.7 B or Gross Profit of 4.4 B, as well as many indicators such as Price To Sales Ratio of 1.6, Dividend Yield of 0.0138 or PTB Ratio of 3.26. Laboratory financial statements analysis is a perfect complement when working with Laboratory Valuation or Volatility modules.
  
Build AI portfolio with Laboratory Stock
Check out the analysis of Laboratory Correlation against competitors.
The Ebit trend for Laboratory of offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Laboratory is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Laboratory's Ebit Growth Pattern

Below is the plot of the Ebit of Laboratory of over the last few years. It is Laboratory's EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Laboratory's overall financial position and show how it may be relating to other accounts over time.
Ebit10 Years Trend
Slightly volatile
   Ebit   
       Timeline  

Laboratory Ebit Regression Statistics

Arithmetic Mean1,315,751,240
Geometric Mean1,189,385,092
Coefficient Of Variation47.59
Mean Deviation382,695,449
Median1,173,600,000
Standard Deviation626,149,404
Sample Variance392063.1T
Range2.8B
R-Value0.28
Mean Square Error384731.1T
R-Squared0.08
Significance0.27
Slope35,078,428
Total Sum of Squares6273009.2T

Laboratory Ebit History

2026863.6 M
20251.3 B
20241.2 B
2023772.1 M
20221.4 B
20213.1 B
20202.4 B

Other Fundumenentals of Laboratory

About Laboratory Financial Statements

Investors use fundamental indicators, such as Laboratory's Ebit, to determine how well the company is positioned to perform in the future. Although Laboratory's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
EBIT1.3 B863.6 M
EBITDA2.1 B1.1 B
Ebt Per Ebit 1.02  1.00 
Ebit Per Revenue 0.10  0.17 

Currently Active Assets on Macroaxis

Check out the analysis of Laboratory Correlation against competitors.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is there potential for Health Care Providers & Services market expansion? Will Laboratory introduce new products? Factors like these will boost the valuation of Laboratory. Expected growth trajectory for Laboratory significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.56
Dividend Share
2.88
Earnings Share
10.2
Revenue Per Share
164.953
Quarterly Revenue Growth
0.086
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Laboratory's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Laboratory represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Laboratory's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.